|
HS Code |
315815 |
| Product Name | N-Tert-Butoxycarbonyl-7-Bromoindoline |
| Cas Number | 1110776-99-0 |
| Molecular Formula | C13H16BrNO2 |
| Molecular Weight | 298.18 g/mol |
| Appearance | White to off-white solid |
| Melting Point | 89-92°C |
| Purity | Typically ≥ 98% |
| Storage Temperature | 2-8°C (Refrigerated) |
| Smiles | CC(C)(C)OC(=O)N1CCc2ccc(Br)cc21 |
| Iupac Name | tert-butyl 7-bromo-2,3-dihydro-1H-indole-1-carboxylate |
As an accredited N-Tert-Butoxycarbonyl-7-Bromoindoline factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive N-Tert-Butoxycarbonyl-7-Bromoindoline prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
N-Tert-Butoxycarbonyl-7-Bromoindoline, often known simply as Boc-7-bromoindoline, stands out in the toolbox of organic chemistry. This compound serves as a specialized building block, playing a unique role in applications that require selective indoline derivatization. Since the world of fine chemical synthesis depends so much on both purity and versatility, Boc-7-bromoindoline deserves attention for its mix of stable protection and reactive design.
The molecule brings together two powerful features: the indoline framework, known for its stability and pi-rich aromaticity, and the tert-butoxycarbonyl (Boc) protecting group at the nitrogen. With a bromo substituent at the 7-position, this structure enables targeted transformations that chemists rarely find elsewhere. Its chemical formula, C13H16BrNO2, and a molar mass near 298.18 g/mol, point to a robust intermediate that balances bulk with reactivity. In a practical sense, the Boc group shields the indoline nitrogen during demanding conditions, letting reactions target other parts of the molecule. This selective protection means fewer unwanted byproducts and less time spent chasing down purification issues.
If you’ve ever dealt with deprotection headaches or tried to fine-tune reaction pathways with more basic indoline variants, you already know the struggle of maintaining both reactivity and control. The Boc group resists both acidic and neutral conditions but surrenders quickly to mild acid, simplifying downstream work. Many labs appreciate that approach: get through your synthetic marathon, then trim off the Boc group right at the finish line with minimal fuss.
The story picks up intensity with the bromo atom. A bromine at the 7-position opens doors for Suzuki, Heck, or Buchwald-Hartwig coupling. In real-world terms, that means a chemist can tack on aromatic groups, amines, or heterocycles with crisp precision. Each swap creates a distinctive compound, which matters in drug discovery or material science. At the bench, being able to direct substitution specifically to the 7-position reduces the guesswork and the tedium of regioisomer separation.
Compare this to unsubstituted indolines, which rarely offer the same breadth for customization. If you care about building variety, whether you’re in the middle of a medicinal library search or tailoring ligands for catalysis, this specific bromo-indoline hybrid is a less-traveled but highly rewarding path.
Painstaking work goes into constructing small-molecule probes, pharmaceutical intermediates, and novel catalysts. Having Boc-7-bromoindoline in the toolkit adds efficiency at several steps. Protected indolines like this one let researchers step through multi-stage syntheses without backtracking. By blocking the nitrogen, the compound withstands strong bases or oxidants, meaning multi-functional sequences stay on track. After the heavy-lifting is over, removing the Boc group re-exposes the indoline nitrogen for further chemistry.
From my perspective, the difference shows up clearly during medicinal chemistry campaigns. Screening programs often run dozens of small modifications off a core scaffold. Boc-7-bromoindoline allows for rapid, parallel functionalization, shrinking the time it takes to iterate on lead compounds. The fact that the bromo substituent enables cross-couplings—one of the most widely used reactions in modern organic synthesis—lowers barriers for scalable route development. You end up spending more time focusing on structure-activity relationships, less rerunning separations or dealing with unstable intermediates.
It’s easy to think any indoline will suffice, but the details prove otherwise. Simple indoline lacks both the tunability of selective halogenation and the security of nitrogen protection. Unprotected indoline derivatives attract side reactions, especially under basic or oxidative conditions. The Boc group not only manages this risk but also brings logistical advantages: longer shelf-life, lower tendency toward polymerization, improved handling—especially when stored over months or years.
As for halogen position, alternatives like 5-bromo or 4-bromo indolines shift the reactivity map considerably. The 7-position, though less mainstream, slots into settings where other isomers cannot reach. The directionality affects both electronic and steric features of the indoline. In certain natural product syntheses or proprietary functional molecules, this detail can make or break the entire route. A comparison with N-acetyl or N-methyl indolines underscores a larger point: Boc protection removes with milder conditions, freeing synthesis from harsh acids or tricky decomposition. Fewer side reactions, less degradation, and better compatibility with fragile functional groups all add up.
Working with protected indoline derivatives comes with its own rhythm. I remember joining a team focused on CNS-active scaffolds. We often started with Boc-7-bromoindoline because it handled library synthesis rounds with grace. Others on the team shared the same assessment—when you’re in the thick of sequential reactions, not worrying about competitive nitrogen alkylation lets planning stay clear-eyed. The Boc group’s removal—using TFA or even milder acids—felt almost ceremonial, often because we’d gotten through the tightrope-walk of cross-coupling and needed perfect conditions for the next stage.
The ability to store this intermediate for extended periods gave us breathing room between experiment runs. Unlike some less stable indoline derivatives, which could yellow or degrade on the shelf, this compound remained stubbornly unchanged. It’s a quiet benefit but a real asset for any workflow facing delays, interruptions, or scale-up transitions.
The real-world impact of Boc-7-bromoindoline comes from its reliability through purification and transformation. Beyond cross-coupling, the 7-bromo handle allows for rapid attachment of alkenes, aryls, or even alkynes. Several peer-reviewed studies cite its role in the shortest syntheses of meroterpenoids, tryptamine analogues, or fluorescence probes. Its consistent rate of reaction, both in small test batches and larger pilots, means tech transfer and reproducibility take fewer troubleshooting loops.
The metabolic stability provided by Boc protection also matters. Some groups have shown that intermediates protected by Boc withstand metabolic simulation protocols more gracefully than those using acetyl, carbamate, or phosphate groups. While this doesn’t translate directly to in vivo stability, it does indicate smoother development for compounds facing preclinical validation.
In an era where reproducibility stands front and center, the transparent characterization offered on Boc-7-bromoindoline matters. NMR, MS, and HPLC traces available from reputable suppliers ensure what arrives matches the spec. Lots tend to be accompanied by spectral libraries, making cross-checking straightforward. Spotting the correct Boc stretching frequencies and bromo-aryl signals gives confidence during both routine and analytical work. While this may seem a dry technical detail, it’s one that kept our team’s projects from running off track on more than one occasion.
Keeping things on a human level, knowing a batch comes from an auditable supply chain—rather than a questionable source—means your research time goes further. Universities and smaller start-ups often have to stretch tight budgets; having reliable Boc-7-bromoindoline in stock kept us from wasting both reagents and effort.
Like many bromo-organics, Boc-7-bromoindoline calls for thoughtful handling. Despite its stability, reactions involving strong acids or bases demand protective gear and adequate ventilation. Spills clean up with common lab absorbents, and safe disposal routes keep bromine content away from municipal systems. I always appreciated that fewer side reactions during synthesis translated to less solvent waste, less need for evaporative concentration, and fewer column purifications. The combination of stability and selective protection, in my experience, lines up with greener chemistry by reducing resource consumption.
Sourcing the compound from suppliers adhering to environmental stewardship—those using renewable feedstocks or capturing process emissions—pushes labs further toward responsible practice. While no synthetic route proves entirely benign, clarity in bottle labeling, batch traceability, and consistent physical parameters steer labs away from avoidable hazards.
The next few years could see broader utility for this protected indoline. Growing interest in site-specific bioconjugation and molecular imaging often means looking for intermediates that play nice with biological substrates. The stability of Boc-protected indoline, combined with selective reactivity at the bromo position, suggests emerging opportunities in late-stage functionalization—especially for peptide-drug conjugates, fluorophore labeling, or targeted probes.
Synthetic methods that work at low temperatures or with minimal excess reagents rely heavily on predictably protected building blocks. Boc-7-bromoindoline supports this need. Newer catalysis platforms, including nickel- or copper-catalyzed couplings, keep finding creative ways to coax value out of this structure. The cost and labor savings speak for themselves; each successful use trims weeks from development timelines and brings novel compounds to testing phases sooner.
Any discussion of the future has to address scale. The shift toward batch-to-flow chemistry highlights intermediates that won’t clog columns, precipitate in tubes, or break down under mild heat. This compound, in the runs I’ve seen, adapts seamlessly to microscale and gram-scale syntheses, further cementing its place in today’s high-throughput labs.
Despite its utility, one persistent challenge involves access in educational and small-scale environments. Regional supply chain disruptions, tight customs protocols for bromo-substituted organics, and limited on-campus stocking all raise the barrier for underfunded labs. Greater sharing of safe handling guidelines and more community-driven protocols could help close this gap. Online repositories, open-access journals, and collaborative consortia—where researchers upload their synthetic routes and safety notes—make it easier for students and new researchers to work confidently with Boc-7-bromoindoline.
Supplier initiatives focused on smaller, researcher-friendly aliquots, improved hazard labeling, or “starter kits” for less experienced users also lower the learning curve. I remember guiding undergraduates through their first manipulations of this compound, and with step-by-step protocols, the anxiety faded away. The more approachable the product, the broader its adoption, and the wider the field of discoveries it enables.
Every synthetic chemist stares down bottlenecks sooner or later: protection group mismatches, purification nightmares, or sluggish reactions. Boc-7-bromoindoline doesn’t solve every problem, but it does address a handful of key pain points. Its thermal stability, single-step deprotection, and broad cross-coupling compatibility eliminate hours of troubleshooting. Applying slightly acidic conditions restores the free indoline while avoiding side reactions that plague more delicate intermediates.
On the scale-up side, clear solubility in common organic solvents—dichloromethane, ethyl acetate, or acetonitrile—means less trial and error for solution-phase synthesis. The compound’s clean chromatographic profile (as seen in routine HPLC runs) saves money on costly silica and reduces run times. Most high-yield transformations published with Boc-7-bromoindoline report minimal need for extensive purification, a marked improvement over unprotected indolines or di-substituted variants.
The divide between industry and academia often feels like an impassable gulf, with academic teams chasing novelty while industry focuses on efficiency and throughput. Boc-7-bromoindoline forms a bridge between these worlds. The robust protection and versatile bromo functionality fit both exploratory research and GMP pathway validation. This shared ground means more cross-pollination of ideas, with academic discoveries reaching market faster and industrial workflows borrowing innovations first tested in university settings.
Anecdotes from colleagues who switched careers bear this out: projects that once felt limited by clunky intermediates or multi-day purifications now move forward at a faster clip. With better access to protected and pre-functionalized indolines, a greater diversity of medicinal chemists, materials scientists, and chemical biologists can collaborate fruitfully. This compound doesn’t just support chemistry; it nudges the research ecosystem toward speedier, more reliable results.
Many modern research programs grapple with patent thickets around scaffold modifications and protection strategies. Boc-7-bromoindoline, owing to its clean modular structure, helps sidestep some of the complexity. Unlike protected indolines burdened by overlapping claims or proprietary production, this variant shows up in both publicly funded and commercial research, enabling broader innovation without overhanging restrictions.
Sharing results openly, particularly negative ones, invigorates discovery. Publishing both successful routes and failed attempts using Boc-7-bromoindoline builds a more honest map of its capabilities. As labs publish comparative yields, telescoped (one-pot) methodologies, and compatibility with novel reagents, everyone benefits from richer collective knowledge. In my own experience, open communication—at conferences or through preprint archives— closes the gap between expectation and practice, reducing wasted cycles and driving more creative deployment of this tool.
Students entering organic synthesis today stand on the shoulders of decades of optimization. Boc-7-bromoindoline forms an ideal teaching example to illustrate the interplay between protection, reactivity, and selectivity. A guided project from bromoindoline derivatization through deprotection, cross-coupling, and final product isolation lets students build confidence and technical savvy. Watching their skills grow as they master air-free techniques, develop new purification strategies, and interpret spectra highlights both the versatility and reliability of this compound.
Hand-on experience with modern intermediates frames the real challenges facing researchers and forges the resilience demanded in innovation-driven environments. As an educator or mentor, seeing students transition from hesitant pipetting to bold experiment design reminds me that reliable, well-characterized compounds like Boc-7-bromoindoline shape not just individual research outcomes, but the careers of the next wave of chemists.
Looking across a career spent with diverse protection strategies, lab environments, and project goals, I see N-Tert-Butoxycarbonyl-7-Bromoindoline as more than a chemical—it’s a catalyst for progress. Its skillful protection, smart reactivity, and trustworthy purity set the stage for both creative breakthroughs and day-to-day dependability. Whether it’s helping an industrial team meet production targets or powering a student’s first successful coupling reaction, this indoline derivative earns its reputation not by flash, but by steady results.
For labs striving to speed up cycles, secure better outcomes, and keep science moving forward, leveraging proven, thoughtfully designed intermediates moves the work from theoretical ambition to published discovery. Boc-7-bromoindoline gives researchers the control, reliability, and creativity required for both ambitious projects and the routine synthesis that underpins our field. In chemistry, as in life, trusted foundations make all the difference.